Inhibition of the TRPC5 ion channel protects the kidney filter.

Authors: Schaldecker, T  Kim, S  Tarabanis, C  Tian, D  Hakroush, S  Castonguay, P  Ahn, W  Wallentin, H  Heid, H  Hopkins, CR  Lindsley, CW  Riccio, A  Buvall, L  Weins, A  Greka, A 
Citation: Schaldecker T, etal., J Clin Invest. 2013 Dec;123(12):5298-309. doi: 10.1172/JCI71165. Epub 2013 Nov 15.
Pubmed: (View Article at PubMed) PMID:24231357
DOI: Full-text: DOI:10.1172/JCI71165

An intact kidney filter is vital to retention of essential proteins in the blood and removal of waste from the body. Damage to the filtration barrier results in albumin loss in the urine, a hallmark of cardiovascular disease and kidney failure. Here we found that the ion channel TRPC5 mediates filtration barrier injury. Using Trpc5-KO mice, a small-molecule inhibitor of TRPC5, Ca2+ imaging in isolated kidney glomeruli, and live imagining of podocyte actin dynamics, we determined that loss of TRPC5 or its inhibition abrogates podocyte cytoskeletal remodeling. Inhibition or loss of TRPC5 prevented activation of the small GTP-binding protein Rac1 and stabilized synaptopodin. Importantly, genetic deletion or pharmacologic inhibition of TRPC5 protected mice from albuminuria. These data reveal that the Ca2+-permeable channel TRPC5 is an important determinant of albuminuria and identify TRPC5 inhibition as a therapeutic strategy for the prevention or treatment of proteinuric kidney disease.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 10043830
Created: 2015-05-29
Species: All species
Last Modified: 2015-05-29
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.